Medi Assist Healthcare Services profit and loss

Latest FY26

Revenue: ₹905cr+25.1% on FY25
EBITDA: ₹175cr+13.3% on FY25
Net profit: ₹89.3cr−2.4% on FY25
EPS: ₹12.14−6.0% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Expenses
	960	905	723	635
	23.2	18.5	23.8	18.3
	983	923	747	653
	416	394	306	254
	12.4	21.4	10.3	3.2
	85.7	77.1	55.8	43.1
	354	336	263	247
	868	829	635	548
	190	175	154	133
	104	97.5	98.3	90.2
Profit
	115	94.5	112	105
	−14.2	−14.2	0.0	−21.0
	101	80.4	112	84.4
	25.7	33.2	26.7	20.5
	−32.5	−42.1	−6.5	−7.4
	−6.8	−9.0	20.2	13.1
	108	89.3	91.5	69.2
	108	89.3	91.6	71.3
	0.0	0.0	−0.1	−2.1
	2.2	2.7	−2.2	1.4
	110	92.0	89.3	70.6
	107	87.9	90.9	66.9
	1.0	1.4	0.6	2.2
Per share
	₹14.43	₹12.14	₹12.91	₹9.71
	₹14.43	₹12.14	₹12.85	₹9.53
Continuing & discontinued operations
	0.0	0.0	−0.1	−2.7
	0.0	0.0	0.0	−0.6
Other comprehensive income — detail
	2.2	2.7	−2.2	—
	−1.1	−1.0	−4.5	0.7
	−0.3	−0.2	−1.1	—
	—	—	—	−0.0
	3.0	3.5	—	0.7
	0.0	0.0	−1.1	—
	108	89.2	88.2	68.0
	1.8	2.8	1.1	2.5
Per share — as-filed variants
	₹14.43	₹12.14	₹12.92	₹10.02
	₹14.43	₹12.14	₹12.86	₹9.84
	₹0.00	₹0.00	−₹0.01	−₹0.31
	₹0.00	₹0.00	−₹0.01	−₹0.31
Adjusted (ex-exceptional items) — derived
	115	94.5	112	105
	−14.2	−14.2	0.0	−21.0
	122	104	91.5	86.9
	₹16.33	₹14.07	₹12.91	₹12.20

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDIASSIST₹297.90

Medi Assist Healthcare Services Limited

· Banking & Finance

Annual Quarterly₹ CroreMcap ₹2,223 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	634.7	723.3	904.8	959.7
Other Income	18.3	23.8	18.5	23.2
Total Income	653.0	747.1	923.2	982.9
Expenses
+ Employee Benefit Expense	254.4	305.9	394.1	415.6
+ Finance Costs	3.2	10.3	21.4	12.4
+ Depreciation & Amortisation	43.1	55.8	77.1	85.7
+ Other Expenses	247.1	263.3	336.1	354.0
Total Expenses	547.7	635.3	828.7	867.6
EBITDA	133.3	154.1	174.6	190.1
EBIT	90.2	98.3	97.5	104.4
Profit
PBT before Exceptional Items	105.4	111.8	94.5	115.2
+ Exceptional Items	-21.0	0.0	-14.2	-14.2
Pretax Income	84.4	111.8	80.4	101.0
+ Current Tax	20.5	26.7	33.2	25.7
+ Deferred Tax	-7.4	-6.5	-42.1	-32.5
Tax Expense	13.1	20.2	-9.0	-6.8
Net Income	69.2	91.5	89.3	107.8
+ Net Income — Continuing Ops	71.3	91.6	89.3	107.8
+ Net Income — Discontinued Ops	-2.1	-0.1	0.0	0.0
+ Other Comprehensive Income	1.4	-2.2	2.7	2.2
Total Comprehensive Income	70.6	89.3	92.0	110.0
Net Income to Common	66.9	90.9	87.9	106.8
Minority Interest	2.2	0.6	1.4	1.0
Per Share
Basic EPS	9.71	12.91	12.14	14.43
Diluted EPS	9.53	12.85	12.14	14.43
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	-2.7	-0.1	0.0	0.0
+ Tax — Discontinued Operations	-0.6	0.0	0.0	0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	-2.2	2.7	2.2
+ Items NOT to be Reclassified to P&L	0.7	-4.5	-1.0	-1.1
+ Tax on Items NOT to be Reclassified	—	-1.1	-0.2	-0.3
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	—	—	—
+ Items to be Reclassified to P&L	0.7	—	3.5	3.0
+ Tax on Items to be Reclassified	—	-1.1	0.0	0.0
Comprehensive Income — Owners of Parent	68.0	88.2	89.2	108.1
Comprehensive Income — Non-controlling Interests	2.5	1.1	2.8	1.8
Per Share — as-filed variants
Basic EPS — Continuing Operations	10.02	12.92	12.14	14.43
Diluted EPS — Continuing Operations	9.84	12.86	12.14	14.43
Basic EPS — Discontinued Operations	-0.31	-0.01	0.00	0.00
Diluted EPS — Discontinued Operations	-0.31	-0.01	0.00	0.00
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	105.4	111.8	94.5	115.2
− Exceptional Items (reconciliation)	-21.0	0.0	-14.2	-14.2
Net Income Adj (tax-effected)	86.9	91.5	103.5	122.0
EPS Adj	12.20	12.91	14.07	16.33
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	5.00	5.00	5.00	5.00
Filed Debt Equity	0.00	0.30	0.61	0.00
Filed Dscr	0.00	0.45	0.90	0.00
Filed Iscr	0.00	14.96	4.55	0.00
Paid Up Equity Capital	35.1	35.3	37.3	37.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.